Pet Cancer Therapeutics Market Report by Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Combination Therapy, and Others), Animal Species (Cats, Dogs, and Others), Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), End User (Veterinary Hospitals and Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033

Pet Cancer Therapeutics Market Report by Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Combination Therapy, and Others), Animal Species (Cats, Dogs, and Others), Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), End User (Veterinary Hospitals and Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4472

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Pet Cancer Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Therapy
    6.1    Chemotherapy
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Radiation Therapy
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Immunotherapy
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Combination Therapy
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Animal Species
    7.1    Cats
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Dogs
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Cancer Type
    8.1    Lymphoma
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Mast Cell Cancer
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Melanoma
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Mammary and Squamous Cell Cancer
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End User
    9.1    Veterinary Hospitals and Clinical Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AB Science
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Boehringer Ingelheim International GmbH
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 SWOT Analysis
        15.3.3    Elanco Animal Health Incorporated
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
        15.3.4    ELIAS Animal Health LLC
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Karyopharm Therapeutics
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Pfizer Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Regeneus Ltd.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    Rhizen Pharmaceuticals AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Torigen Pharmaceuticals Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    VetDC Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    Virbac
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Zoetis Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

​Figure 1: Global: Pet Cancer Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Pet Cancer Therapeutics Market: Breakup by Therapy (in %), 2024
Figure 5: Global: Pet Cancer Therapeutics Market: Breakup by Animal Species (in %), 2024
Figure 6: Global: Pet Cancer Therapeutics Market: Breakup by Cancer Type (in %), 2024
Figure 7: Global: Pet Cancer Therapeutics Market: Breakup by End User (in %), 2024
Figure 8: Global: Pet Cancer Therapeutics Market: Breakup by Region (in %), 2024
Figure 9: Global: Pet Cancer Therapeutics (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Pet Cancer Therapeutics (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Pet Cancer Therapeutics (Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Pet Cancer Therapeutics (Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Pet Cancer Therapeutics (Immunotherapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Pet Cancer Therapeutics (Immunotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Pet Cancer Therapeutics (Combination Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Pet Cancer Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Pet Cancer Therapeutics (Other Therapies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Pet Cancer Therapeutics (Other Therapies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Pet Cancer Therapeutics (Cats) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Pet Cancer Therapeutics (Cats) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Pet Cancer Therapeutics (Dogs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Pet Cancer Therapeutics (Dogs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Pet Cancer Therapeutics (Other Animal Species) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Pet Cancer Therapeutics (Other Animal Species) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Pet Cancer Therapeutics (Lymphoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Pet Cancer Therapeutics (Lymphoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Pet Cancer Therapeutics (Melanoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Pet Cancer Therapeutics (Melanoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Pet Cancer Therapeutics (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Pet Cancer Therapeutics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Pet Cancer Therapeutics (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Pet Cancer Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Pet Cancer Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Pet Cancer Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: North America: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: North America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: United States: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: United States: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Canada: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Canada: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Asia-Pacific: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Asia-Pacific: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: China: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: China: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Japan: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Japan: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: India: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: India: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: South Korea: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: South Korea: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Australia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Australia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Indonesia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Indonesia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Europe: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Europe: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Germany: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Germany: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: France: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: France: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: United Kingdom: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: United Kingdom: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Italy: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Italy: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Spain: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Spain: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Russia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Russia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Latin America: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Latin America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Brazil: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Brazil: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Mexico: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Mexico: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Middle East and Africa: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Middle East and Africa: Pet Cancer Therapeutics Market: Breakup by Country (in %), 2024
Figure 91: Middle East and Africa: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Global: Pet Cancer Therapeutics Industry: SWOT Analysis
Figure 93: Global: Pet Cancer Therapeutics Industry: Value Chain Analysis
Figure 94: Global: Pet Cancer Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pet Cancer Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Therapy (in Million USD), 2025-2033
Table 3: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Animal Species (in Million USD), 2025-2033
Table 4: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
Table 5: Global: Pet Cancer Therapeutics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Pet Cancer Therapeutics Market: Competitive Structure
Table 8: Global: Pet Cancer Therapeutics Market: Key Players

Pet Cancer Therapeutics Market Report by Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Combination Therapy, and Others), Animal Species (Cats, Dogs, and Others), Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others), End User (Veterinary Hospitals and Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials